Scout | Development of Cancer Immunoprevention Agents

This opportunity is no longer accepting applications.

grant

Development of Cancer Immunoprevention Agents

This grant opportunity is for the development of therapeutic cancer vaccines and immunomodulatory drugs for cancer prevention and interception, especially for non-virus-caused cancers. It targets high-risk populations, such as those with genetic mutations, precancers, or exposure to carcinogens. The grant supports small businesses in translating preclinical findings into clinical applications.…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: August 2, 2024

Open for Submission: August 2, 2024

Application Window Closes: October 18, 2024

Keywords

Cancer immunoprevention

prophylactic vaccines

immunomodulatory drugs

tumor prevention

high-risk populations

preclinical research

cancer prevention

immune mechanisms

small business development

commercialization.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers